Basal insulin glargine vs prandial insulin lispro in type 2 diabetes

The Lancet

Volumn 372, Issue 9636, 2008, Pages 371-372

  Oliveira, Juliana Helena ^a   Kazda, Cristof ^a   Simpson, Alexander ^a   Jackson, Jeffrery A ^a   Heine, Robert J ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN GLARGINE; INSULIN LISPRO; ORAL ANTIDIABETIC AGENT; ANTIDIABETIC AGENT; DRUG DERIVATIVE; GLARGINE; INSULIN; GLYCOSYLATED HEMOGLOBIN;

BLOOD GLUCOSE MONITORING; CLINICAL PRACTICE; CLINICAL TRIAL; HEMOGLOBIN BLOOD LEVEL; HUMAN; LETTER; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; BLOOD; CHEMICALLY INDUCED DISORDER; DIET RESTRICTION; DOSE RESPONSE; HYPOGLYCEMIA; NOTE; DRUG EFFECT;

DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; FASTING; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; HEMOGLOBIN A, GLYCOSYLATED;

EID: 48149084293     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)61153-8     Document Type: Letter

References (5)

1. Bretzel R., Nuber U., Landgraf W., et al. Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial. Lancet 371 (2008) 1073-1084
2. Kazda C., Hülstrunk H., Helsberg K., et al. Prandial insulin substitution with insulin lispro or insulin lispro mid mixture vs. basal therapy with insulin glargine: a randomized controlled trial in patients with type 2 diabetes beginning insulin therapy. J Diabetes Complications 20 (2006) 145-152
3. Holman R., Thorne K., Farmer A., et al. Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes. N Engl J Med 357 (2007) 1716-1730
4. Nathan D., Buse J., Davidson M., et al. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: update regarding thiazolidinediones: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 31 (2008) 173-175
5. Monnier L., Lapinski H., and Collette C. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c). Diabetes Care 26 (2003) 881-885